In the present study, analysis of ESCC immunostaining and clinical data revealed that low GCH1 expression was a significantly poor prognostic factor, whereas no significant prognostic difference was observed for GPX4 and FSP1 expression. This evidence concerns the gene GPX4 and esophageal squamous cell carcinoma.